Spectral ai outlines u.s. regulatory pathway for deepview® system for burn indication

Dallas, sept. 17, 2024 (globe newswire) -- spectral ai, inc. (nasdaq: mdai) (“spectral ai” or the “company”), an artificial intelligence (ai) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today provided an outline of its regulatory pathway strategy to enter the u.s. market with its flagship deepview® system for burn indication (“deepview ai®-burn”).
MDAI Ratings Summary
MDAI Quant Ranking